Lirum Therapeutics Participates in the 13th Annual LifeSci Partners Corporate Access Event tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Press release Stockholm, Sweden, January 8, 2024 Mendus AB , a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced that it will participate in the.
Data from seven different clinical studies expected throughout the year, including combination data for the two lead programs BI-1808 and BI-1206 in H1/mid-2024Well-financed with 1358 SEK million , as.
BioInvent International: BioInvent Announces 2024 Strategic Priorities and Anticipated Milestones finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.